Warning: The NCBI web site requires JavaScript to function. more...
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gómez-García L, Vargas A, Bojalil R.
Arthritis Res Ther. 2006;8(5):R144.
Related citations
Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
Damián-Abrego GN, Cabiedes J, Cabral AR.
Lupus. 2008 Apr;17(4):300-4.
What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
Zhao Y, Li J, Li XX, Li C, Li L, Li ZG.
Joint Bone Spine. 2009 Oct;76(5):501-7. Epub 2009 Mar 16.
Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.
J Rheumatol. 2004 Sep;31(9):1829-33.
The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.
Lupus. 2009 Jul;18(8):713-7.
Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Kuwata S, Takeuchi F.
Clin Rheumatol. 2010 Mar;29(3):241-6. Epub 2009 Nov 29.
Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.
J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.
[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.
Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, Hahn PC, Chan EK, Reeves WH, Satoh M.
J Rheumatol. 2009 Dec;36(12):2682-90. Epub 2009 Nov 2.
Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
Arthritis Res Ther. 2006;8(6):R162.
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
Becker-Merok A, Nikolaisen C, Nossent HC.
Lupus. 2006;15(9):570-6.
The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
Scand J Rheumatol. 2008 May-Jun;37(3):183-7.
Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G, Soós L, Fekete A, Szabó Z, Zeher M, Horváth IF, Dankó K, Kapitány A, Gyetvai A, Szegedi G, Szekanecz Z.
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):253-60.
Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
J Rheumatol. 2009 Apr;36(4):712-6. Epub 2009 Mar 13.
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.
Ann Rheum Dis. 2009 May;68(5):736-43. Epub 2008 Jul 17.
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewé R, Ødegård S, Kvien TK, Molberg Ø.
Ann Rheum Dis. 2008 Mar;67(3):414-7. Epub 2007 Nov 15.
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.
Arthritis Rheum. 2008 Jan;58(1):36-45.
'Rhupus' syndrome.
Panush RS, Edwards NL, Longley S, Webster E.
Arch Intern Med. 1988 Jul;148(7):1633-6.
Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.
Caramaschi P, Biasi D, Tonolli E, Pieropan S, Martinelli N, Carletto A, Volpe A, Bambara LM.
Rheumatol Int. 2005 Nov;26(1):58-62. Epub 2005 Feb 23.
Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
Shankar S, Grover R, Handa R.
Indian J Med Res. 2006 Dec;124(6):689-96.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on